8-K ·Filed Apr 14, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
Monitor the company's upcoming presentation at the Needham conference for insights into commercial traction and adoption rates of the LIBERTY system, which could signal future revenue potential.
Final — all horizons settled through T+60d ⚠ clustered
MBOT ▼ -23.46% at T+60d
NEUTRAL call -23.46% · α vs SPY -31.98% · entry $2.43 → $1.86
T+1d
-1.65%
call -1.65% · α -2.42%
$2.39
settled 6mo ago
T+5d
-11.52%
call -11.52% · α -12.92%
$2.15
settled 6mo ago
T+20d
-9.88%
call -9.88% · α -16.17%
$2.19
settled 6mo ago
T+60d
-23.46%
call -23.46% · α -31.98%
$1.86
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Microbot Medical announced the full market release of its LIBERTY Endovascular Robotic System and will present at the Needham Virtual Healthcare Conference. This marks a commercial milestone for the company's FDA-cleared robotic technology.
Key Facts
- Microbot Medical completed limited market release and commenced full market release of the LIBERTY Endovascular Robotic System
- The LIBERTY system is FDA-cleared for peripheral endovascular procedures
- Company will present at the 25th Annual Needham Virtual Healthcare Conference
- Presentation will cover commercial achievements, strategic positioning, and growth opportunities
Financial Impact
Commercial milestone achievement with potential for future revenue growth from full market release
revenuemarket adoption
Risk Factors
- Commercial success depends on market adoption of the robotic system
- Competition in the robotic surgery space
- Regulatory risks for future product developments
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-016484 |
| Exhibit: ex99-1.htm | 0001493152-26-016484 |
| Document: 0001493152-26-016484-index-headers.html | 0001493152-26-016484 |
| Document: 0001493152-26-016484-index.html | 0001493152-26-016484 |
| Document: 0001493152-26-016484.txt | 0001493152-26-016484 |
22 reports for MBOT
33% Hit rate @ T+1 Went positive at some point 4 of 6 best @ T+5▲ +9.39%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9799 | awaiting T+1 | — | $0.9826 (+0.28%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9826 (+3.70%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9826 (−8.17%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9826 (−8.17%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9826 (−21.39%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9826 (−41.51%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9826 (−45.41%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9826 (−48.28%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9826 (−49.61%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9826 (−46.01%) |
Showing 10 of 22
US Market Status
Market Open — Closes in 4h 10m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers